| June 30, | ||||||||
| 2017 | 2016 | |||||||
| Deferred Tax Assets | ||||||||
| Net operating loss | $ | 13,314 | $ | 13,967 | ||||
| Capital loss carryover | 31 | 31 | ||||||
| Valuation adjustment on investment in iBio, Inc. | 707 | 695 | ||||||
| Depreciation | (269 | ) | (166 | ) | ||||
| Inventory | 139 | 156 | ||||||
| Change in estimated fair value of derivative liability | 201 | 31 | ||||||
| Other | 94 | - | ||||||
| Valuation allowance | (13,394 | ) | (14,714 | ) | ||||
| Total deferred tax asset, net | $ | 823 | $ | - | ||||
| For the fiscal year | ||||||||
| ended June 30, | ||||||||
| 2017 | 2016 | |||||||
| Current - Federal | $ | 30 | $ | 20 | ||||
| Current - State and local | 306 | 211 | ||||||
| Deferred - Federal and state | 495 | 114 | ||||||
| Change in valuation allowance | (1,321 | ) | (114 | ) | ||||
| Income tax (benefit) expense, net | $ | (490 | ) | $ | 231 | |||
| For the fiscal year | ||||||||
| ended June 30, | ||||||||
| 2017 | 2016 | |||||||
| Statutory federal income tax rate | 34 | % | 34 | % | ||||
| Statutory state income tax rate | 6 | % | 6 | % | ||||
| Effective state income tax rate | 10 | % | 12 | % | ||||
| Change in valuation allowance | (79 | )% | (36 | )% | ||||
| Non-deductible expenses | 3 | % | 3 | % | ||||
| Effective income tax rate | (26 | )% | 19 | % | ||||